Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine

This study, published in The New England Journal of Medicine, evaluated the safety and efficacy of Merck’s rotavirus vaccine (RotaTeq®), with a focus on determining risk of intussusception.

Author(s): Vesikari T, Matson D, Dennehy P, et al.

Published: 2006

  • Visit web page (English)

    (Located at content.nejm.org)

    Citation: Vesikari T, Matson D, Dennehy P, et al. Safety and Efficacy of a Pentavalent Human-bovine (WC3) Reassortant Rotavirus Vaccine. New England Journal of Medicine. 2006;354(1):23-33.

  • Download file (French)

    Also known as: Sécurité et efficacité d’un vaccin pentavalent contre le rotavirus humain–bovin réassorti (WC3)

    221 KB PDF

  • Download file (Russian)

    Also known as: Безопасность и эффективность пятивалентной человеческой–бычьей (WC3) реассортативной антиротавирусной вакцины

    254 KB PDF

  • Download file (Spanish)

    Also known as: Seguridad y eficacia de una vacuna antirrotavírica reagrupada humano–bovina (WC3) pentavalente

    216 KB PDF

Resource types: Peer-reviewed journal

Diseases: Rotavirus

Topics: Vaccine safety; Disease/vaccine specific information

Regions: Global